Dosidal · Switzerland
Eribulin Advanz Pharma, Injektionslösung
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Switzerland |
|---|---|
| Record | ch:authorisation:69924 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | swissmedic-authorisation: 69924 atc: L01XX41 |
| Source authority | Swissmedic |
| Read date | |
| authorisation status | first_authorisation: 2025-06-26 term: zugelassen valid_until: 2030-06-25 state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| identity | atc: L01XX41 authorisation_number: 69924 form: LSINJ holder: Advanz Pharma Specialty Medicine holder_partner_nr: 1101402 it_number: 07.16.1. name: Eribulin Advanz Pharma, Injektionslösung state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53vRGWlt9audA_7rf_axEQfNfNjixAUF6nkGg6rBXh83aV9ypHSaK-C4zsLYxxdgoSE_bzvFoVMwa6batB7s35PQVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |
JSON: https://dosidal-api.ai/v1/records/ch:authorisation:69924 · Related records in other markets · Dosidal